|
1
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guan Z, Yu X, Wang H, Wang H, Zhang J, Li
G, Cao J and Teng L: Advances in the targeted therapy of
liposarcoma. Onco Targets Ther. 8:125–136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duong CP, Yong CS, Kershaw MH, Slaney CY
and Darcy PK: Cancer immunotherapy utilizing gene-modified T cells:
From the bench to the clinic. Mol Immunol. 67:46–57. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kong FM, Zhao J, Wang J and Faivre-Finn C:
Radiation dose effect in locally advanced non-small cell lung
cancer. J Thorac Dis. 6:336–347. 2014.PubMed/NCBI
|
|
7
|
Brady LW, Kramer S, Levitt SH, Parker RG
and Powers WE: Radiation oncology: Contributions of the United
States in the last years of the 20th century. Radiology. 219:1–5.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alamanda VK, Song Y, Shinohara E, Schwartz
HS and Holt GE: Postoperative radiation boost does not improve
local recurrence rates in extremity soft tissue sarcomas. J Med
Imaging Radiat Oncol. 58:633–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao CN, Luo JW, Gao L, Xu GZ, Li SY and
Xiao JP: Recurrence of nasopharyngeal carcinoma in the parotid
region after definitive intensity-modulated radiotherapy. J Oral
Maxillofac Surg. 71:1993–1997. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Milas L, Raju U, Liao Z and Ajani J:
Targeting molecular determinants of tumor chemo-radioresistance.
Semin Oncol. 32 Suppl 9:S78–S81. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brach MA, Gruss HJ, Kaisho T, Asano Y,
Hirano T and Herrmann F: Ionizing radiation induces expression of
interleukin 6 by human fibroblasts involving activation of nuclear
factor-kappa B. J Biol Chem. 268:8466–8472. 1993.PubMed/NCBI
|
|
12
|
Yin ZJ, Jin FG, Liu TG, Fu EQ, Xie YH and
Sun RL: Overexpression of STAT3 potentiates growth, survival, and
radioresistance of non-small-cell lung cancer (NSCLC) cells. J Surg
Res. 171:675–683. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guerra LE, Smith RM, Kaminski A, Lagios MD
and Silverstein MJ: Invasive local recurrence increased after
radiation therapy for ductal carcinoma in situ. Am J Surg.
196:552–555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wild-Bode C, Weller M, Rimner A, Dichgans
J and Wick W: Sublethal irradiation promotes migration and
invasiveness of glioma cells: Implications for radiotherapy of
human glioblastoma. Cancer Res. 61:2744–2750. 2001.PubMed/NCBI
|
|
15
|
Cheng JC, Chou CH, Kuo ML and Hsieh CY:
Radiation-enhanced hepatocellular carcinoma cell invasion with
MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction
pathway. Oncogene. 25:7009–7018. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paquette B, Baptiste C, Therriault H,
Arguin G, Plouffe B and Lemay R: In vitro irradiation of basement
membrane enhances the invasiveness of breast cancer cells. Br J
Cancer. 97:1505–1512. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qian LW, Mizumoto K, Urashima T, Nagai E,
Maehara N, Sato N, Nakajima M and Tanaka M: Radiation-induced
increase in invasive potential of human pancreatic cancer cells and
its blockade by a matrix metalloproteinase inhibitor, CGS27023.
Clin Cancer Res. 8:1223–1227. 2002.PubMed/NCBI
|
|
18
|
Hsu TI, Wang MC, Chen SY, Yeh YM, Su WC,
Chang WC and Hung JJ: Sp1 expression regulates lung tumor
progression. Oncogene. 31:3973–3988. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zannetti A, Del Vecchio S, Carriero MV,
Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP and Salvatore
M: Coordinate up-regulation of Sp1 DNA-binding activity and
urokinase receptor expression in breast carcinoma. Cancer Res.
60:1546–1551. 2000.PubMed/NCBI
|
|
20
|
Chiefari E, Brunetti A, Arturi F, Bidart
JM, Russo D, Schlumberger M and Filetti S: Increased expression of
AP2 and Sp1 transcription factors in human thyroid tumors: A role
in NIS expression regulation? BMC Cancer. 2:352002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang JP, Zhang H, Wang HB, Li YX, Liu GH,
Xing S, Li MZ and Zeng MS: Down-regulation of Sp1 suppresses cell
proliferation, clonogenicity and the expressions of stem cell
markers in nasopharyngeal carcinoma. J Transl Med. 12:2222014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cho JJ, Chae JI, Yoon G, Kim KH, Cho JH,
Cho SS, Cho YS and Shim JH: Licochalcone A, a natural chalconoid
isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1
and Sp1 regulatory proteins in oral squamous cell carcinoma. Int J
Oncol. 45:667–674. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dynan WS and Tjian R: The
promoter-specific transcription factor Sp1 binds to upstream
sequences in the SV40 early promoter. Cell. 35:79–87. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Borja Fojas P, Collins NK, Du P,
Azizkhan-Clifford J and Mudryj M: Cyclin A-CDK phosphorylates Sp1
and enhances Sp1-mediated transcription. EMBO J. 20:5737–5747.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chuang JY, Wang SA, Yang WB, Yang HC, Hung
CY, Su TP, Chang WC and Hung JJ: Sp1 phosphorylation by
cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding
activity during mitosis in cancer cells. Oncogene. 31:4946–4959.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang HW: COX-2 regulation of
prostaglandins in synaptic signaling. Sheng Li Ke Xue Jin Zhan.
40:317–320. 2009.(In Chinese). PubMed/NCBI
|
|
27
|
Lim HY, Joo HJ, Choi JH, Yi JW, Yang MS,
Cho DY, Kim HS, Nam DK, Lee KB and Kim HC: Increased expression of
cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer
Res. 6:519–525. 2000.PubMed/NCBI
|
|
28
|
Tucker ON, Dannenberg AJ, Yang EK, Zhang
F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT
and Fahey TJ III: Cyclooxygenase-2 expression is up-regulated in
human pancreatic cancer. Cancer Res. 59:987–990. 1999.PubMed/NCBI
|
|
29
|
Molina MA, Sitja-Arnau M, Lemoine MG,
Frazier ML and Sinicrope FA: Increased cyclooxygenase-2 expression
in human pancreatic carcinomas and cell lines: Growth inhibition by
nonsteroidal anti-inflammatory drugs. Cancer Res. 59:4356–4362.
1999.PubMed/NCBI
|
|
30
|
Brown JR and DuBois RN: Cyclooxygenase as
a target in lung cancer. Clin Cancer Res. 10:4266s–4269s. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pruthi RS, Derksen E and Gaston K:
Cyclooxygenase-2 as a potential target in the prevention and
treatment of genitourinary tumors: A review. J Urol. 169:2352–2359.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang CH, Chang HC and Hung WC: p16
inhibits matrix metalloproteinase-2 expression via suppression of
Sp1-mediated gene transcription. J Cell Physiol. 208:246–252. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meng Z and Gan YH: Activating PTEN by
COX-2 inhibitors antagonizes radiation-induced AKT activation
contributing to radiosensitization. Biochem Biophys Res Commun.
460:198–204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kwon YW, Jang S, Paek JS, Lee JW, Cho HJ,
Yang HM and Kim HS: E-Ras improves the efficiency of reprogramming
by facilitating cell cycle progression through JNK-Sp1 pathway.
Stem Cell Res. 15:481–494. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ohuchida K, Mizumoto K, Murakami M, Qian
LW, Sato N, Nagai E, Matsumoto K, Nakamura T and Tanaka M:
Radiation to stromal fibroblasts increases invasiveness of
pancreatic cancer cells through tumor-stromal interactions. Cancer
Res. 64:3215–3222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo L, Xiao Y, Fan M, Li JJ and Wang Y:
Profiling global kinome signatures of the radioresistant MCF-7/C6
breast cancer cells using MRM-based targeted proteomics. J Proteome
Res. 14:193–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Peng G, Cao RB, Li YH, Zou ZW, Huang J and
Ding Q: Alterations of cell cycle control proteins SHP1/2, p16,
CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma
cells. Mol Med Rep. 10:1709–1716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kou XX, Hao T, Meng Z, Zhou YH and Gan YH:
Acetylated Sp1 inhibits PTEN expression through binding to PTEN
core promoter and recruitment of HDAC1 and promotes cancer cell
migration and invasion. Carcinogenesis. 34:58–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Duan H, Heckman CA and Boxer LM: Histone
deacetylase inhibitors down-regulate bcl-2 expression and induce
apoptosis in t(14;18) lymphomas. Mol Cell Biol. 25:1608–1619. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang MY, Lee HT, Chen CM, Shen CC and Ma
HI: Celecoxib suppresses the phosphorylation of STAT3 protein and
can enhance the radiosensitivity of medulloblastoma-derived cancer
stem-like cells. Int J Mol Sci. 15:11013–11029. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim YM, Jeong IH and Pyo H: Celecoxib
enhances the radiosensitizing effect of 7-hydroxystaurosporine
(UCN-01) in human lung cancer cell lines. Int J Radiat Oncol Biol
Phys. 83:e399–e407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang LW, Hsiao CF, Chen WT, Lee HH, Lin
TC, Chen HC, Chen HH, Chien CR, Lin TY and Liu TW: Celecoxib plus
chemoradiotherapy for locally advanced rectal cancer: A phase II
TCOG study. J Surg Oncol. 109:580–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chuang JY, Wang YT, Yeh SH, Liu YW, Chang
WC and Hung JJ: Phosphorylation by c-Jun NH2-terminal kinase 1
regulates the stability of transcription factor Sp1 during mitosis.
Mol Biol Cell. 19:1139–1151. 2008. View Article : Google Scholar : PubMed/NCBI
|
